AviClear results are long-lasting but not guaranteed to be permanent for everyone. In clinical follow-up data, 80% of patients remained in remission nearly three years after treatment, while other studies show a 50% remission rate at two years. Some people never experience a return of acne, while others see oil production gradually creep back and may need occasional maintenance sessions.
How AviClear Works on Oil Glands
AviClear uses a 1726 nm wavelength laser that selectively heats and destroys the oil-producing cells inside sebaceous glands. Tissue samples taken after treatment show complete destruction of these cells, while the surrounding skin, hair follicles, and deeper layers of the dermis remain unharmed. This is a meaningful distinction: the laser isn’t just temporarily shrinking the glands or reducing inflammation. It’s killing the specific cells responsible for excess oil production.
The standard protocol involves three treatment sessions spaced two to five weeks apart, applied to facial skin. In the FDA clearance trial, 77.9% of participants achieved at least a 50% reduction in inflammatory acne lesions by 12 weeks after their final session.
What the Long-Term Data Shows
The strongest evidence for durability comes from follow-up studies tracking patients well beyond the initial treatment period. One study found that 80% of patients were still in remission at 35 months, roughly three years after completing treatment. A separate study reported a 50% remission rate at 24 months. These numbers suggest that AviClear produces results that last significantly longer than most topical or oral acne treatments, but they also make clear that some patients do relapse.
It’s worth noting that the FDA clearance trial itself only formally tracked patients out to one year. The longer follow-up data comes from ongoing research, and there is no published data yet on what happens five or ten years down the line. The technology is still relatively new, having received FDA clearance in 2022, so truly long-term permanence remains an open question.
Why Results Vary Between People
Sebaceous glands don’t exist in isolation. They’re regulated by hormones, genetics, stress, and other factors that vary widely from person to person. For someone whose acne is primarily driven by overactive oil glands and who has relatively stable hormones, AviClear can produce results that feel essentially permanent. The destroyed oil cells don’t come back.
But the body can regenerate sebaceous tissue over time, and hormonal shifts can stimulate remaining or newly formed gland cells to ramp up oil production again. Clinicians report that patients most likely to see a return of oiliness are those with known hormonal triggers: stopping hormonal birth control, entering perimenopause, or dealing with conditions like polycystic ovary syndrome. People who previously relapsed after multiple courses of isotretinoin (Accutane) also tend to be in this group.
For many patients, oil suppression lasts 12 months or longer. Some never relapse. Others notice a slow return of oiliness around the nine-month mark. The variation is expected and depends on the individual’s hormonal stability, genetics, and skin type.
Top-Up Sessions and Maintenance
One practical advantage of AviClear over medications is that maintenance, when needed, is relatively simple. Rather than restarting a months-long drug regimen, patients who experience some return of acne can typically get a single “top-up” laser session six to twelve months after the initial course. This is particularly common for patients with strong hormonal drivers or a history of treatment-resistant acne.
Not everyone needs maintenance. But going in with realistic expectations helps: think of the initial three sessions as the heavy lifting and a possible future session as fine-tuning rather than failure.
How It Compares to Isotretinoin
The closest comparison for long-lasting acne treatment is isotretinoin, which also targets oil production, though through a completely different mechanism (it shrinks sebaceous glands systemically over a four-to-six-month course). Isotretinoin produces long-term remission in roughly 50% to 70% of patients, with the rest experiencing some degree of relapse within a few years. Dermatologists have noted that both approaches produce “very prolonged remission,” but direct head-to-head comparison studies haven’t been published yet.
The key difference is how they get there. Isotretinoin works through your bloodstream and affects oil glands everywhere, carrying well-known side effects including severe dryness, mood changes, and mandatory pregnancy prevention measures. AviClear works locally on the treated area with no systemic side effects, though it does involve discomfort during the sessions themselves. For people who can’t tolerate isotretinoin or prefer to avoid it, AviClear offers a comparable durability profile without the drug-related risks.
The Bottom Line on Permanence
AviClear destroys oil-producing cells in a way that is physically permanent. Those specific cells don’t regenerate. But your body can produce new ones over time, especially under hormonal influence, which is why “permanent” isn’t a simple yes or no. The best available data shows most patients maintain significant improvement for two to three years, with a subset staying clear indefinitely and others benefiting from occasional single-session touch-ups.